NZ181958A - 2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions - Google Patents

2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions

Info

Publication number
NZ181958A
NZ181958A NZ181958A NZ18195876A NZ181958A NZ 181958 A NZ181958 A NZ 181958A NZ 181958 A NZ181958 A NZ 181958A NZ 18195876 A NZ18195876 A NZ 18195876A NZ 181958 A NZ181958 A NZ 181958A
Authority
NZ
New Zealand
Prior art keywords
benzophenones
triazol
substituted
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
NZ181958A
Other languages
English (en)
Inventor
T Ishiba
K Hirai
H Sugimoto
T Fujishita
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NZ181958A publication Critical patent/NZ181958A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/92Oxygen atoms with hetero atoms directly attached to nitrogen atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ181958A 1975-12-30 1976-09-07 2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions NZ181958A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53224/75A GB1531980A (en) 1975-12-30 1975-12-30 Triazolylbenzophenone derivatives and preparation thereof

Publications (1)

Publication Number Publication Date
NZ181958A true NZ181958A (en) 1979-03-28

Family

ID=10467048

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ181958A NZ181958A (en) 1975-12-30 1976-09-07 2-(3-substituted-4h-2,2,4-triazol-4-yi)-benzophenones and pharmaceutical compositions

Country Status (19)

Country Link
JP (1) JPS5283469A (xx)
AR (2) AR218613A1 (xx)
AT (1) AT350052B (xx)
AU (1) AU498113B2 (xx)
BE (1) BE846410A (xx)
CA (1) CA1126274A (xx)
CH (1) CH623315A5 (xx)
DE (1) DE2641164A1 (xx)
DK (1) DK393576A (xx)
ES (3) ES451896A1 (xx)
FR (1) FR2336930A1 (xx)
GB (1) GB1531980A (xx)
HU (1) HU172539B (xx)
IE (1) IE43841B1 (xx)
IL (1) IL50664A (xx)
NL (1) NL7610799A (xx)
NZ (1) NZ181958A (xx)
SE (1) SE7609813L (xx)
ZA (1) ZA765851B (xx)

Also Published As

Publication number Publication date
AT350052B (de) 1979-05-10
IL50664A0 (en) 1976-12-31
DE2641164A1 (de) 1977-07-14
FR2336930B1 (xx) 1978-12-22
BE846410A (fr) 1977-01-17
JPS5283469A (en) 1977-07-12
IL50664A (en) 1983-09-30
ES462244A1 (es) 1978-06-01
ATA684276A (de) 1978-10-15
HU172539B (hu) 1978-09-28
ZA765851B (en) 1977-09-28
SE7609813L (sv) 1977-07-01
GB1531980A (en) 1978-11-15
DK393576A (da) 1977-07-01
IE43841B1 (en) 1981-06-03
AU1749876A (en) 1978-03-16
CH623315A5 (en) 1981-05-29
AU498113B2 (en) 1979-02-08
CA1126274A (en) 1982-06-22
ES451896A1 (es) 1978-01-16
FR2336930A1 (fr) 1977-07-29
IE43841L (en) 1977-06-30
ES462243A1 (es) 1978-06-01
AR220519A1 (es) 1980-11-14
NL7610799A (nl) 1977-07-04
AR218613A1 (es) 1980-06-30

Similar Documents

Publication Publication Date Title
ZA7671B (en) Pharmaceutical composition
NZ186197A (en) 3,4,5-trimethoxybenzene derivatives and pharmaceutical compositions
JPS5272829A (en) Pharmaceutical composition
GR61176B (en) Pharmaceutical compositions and process for the preparation thereof
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
PH12974A (en) 6,7-benzomorphan derivatives and their pharmaceutical composition
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
NZ179835A (en) Aminoalkynoic acids,derivatives and pharmaceutical compositions
NZ185965A (en) 5'-deoxy-5-fluor ocytidine, 5'-deoxy-5-fluoro-uridine and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
IL49424A0 (en) 1,1,1-triaryl-alkylamines,their preparation and pharmaceutical compositions containing them
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
IL49931A (en) Pharmaceutical compositions comprising 1-phenyl-2,3,4,5-tetrahydro-1h-benzazepine derivatives and certain new such compounds
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
IL49132A (en) 16,1l-disubstituted androst-4-en-3-ones,their preparation and pharmaceutical compositions containing them
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ182502A (en) 1,4-dihydro-2,6-dimethyl-3-methoxycarbonyl-5-isobut-oxycarbonyl-4-(21-nitrophenyl)-pyridine and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NZ187825A (en) 1,2,4-oxadiazole derivatives and pharmaceutical compositions
NZ182716A (en) 4-(7-bromo-5-methoxy-2-benzofuranyl)-1,2,3,6-tetrahtdropyridine or-piperidine derivatives and pharmaceutical compositions
NZ180863A (en) 3,5-bisoxygenated 2-(w-halo-3-oxygenated-1-alkenyl)-cyclopentane-1-heptanoic acid derivatives and pharmaceutical compositions